SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C/A - Offering Statement: [Amend]
SEC Accession No. 0001669191-21-000875
Filing Date
2021-09-10
Accepted
2021-09-10 14:00:54
Documents
8

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C/A  
1 primary_doc.xml C/A 10204
2 OFFERING STATEMENT PDF offeringstatement.pdf EX-99 102178
3 OFFERING PAGE JPG offeringpage.jpg GRAPHIC 1477164
4 CPA REVIEW REPORT reviewletter.pdf EX-99 583504
5 CERTIFICATE OF INCORPORATION certificateofincorporation.pdf EX-99 1419459
6 CORPORATE BYLAWS corporatebylaws.pdf EX-99 243726
7 ADDITIONAL INFORMATION otherfinancial.pdf EX-99 157305
8 IMAGE ATTACHMENTS HTML imageattachments.htm EX-99 244
  Complete submission text file 0001669191-21-000875.txt   5488448
Mailing Address 2145 S CLERMONT ST SUITE 3 DENVER CO 80222
Business Address 2145 S CLERMONT ST STE 3 DENVER CO 80222 5106982462
Canine Life Sciences Inc. (Filer) CIK: 0001857342 (see all company filings)

IRS No.: 844068759 | State of Incorp.: CO
Type: C/A | Act: 33 | File No.: 020-28727 | Film No.: 211246702